|
Clinical variables
| | |
|
Age
|
1.03 (1.01-1.05
|
0.001
|
|
Female Gender
|
2.00 (1.31-3.07)
|
0.002
|
|
Diabetes Mellitus
|
1.26 (0.82-1.940
|
0.3
|
|
Hypertension
|
0.95 (0.62-1.46)
|
0.8
|
|
Statins
|
0.74 (0.49-1.12)
|
0.1
|
|
Beta-blockers
|
0.71 (0.47-1.06)
|
0.1
|
|
Angiotensin converting enzyme-inhibitors
|
0.75 (0.49-1.14)
|
0.2
|
|
Aldosterone antagonists
|
1.17 (0.74-1.86)
|
0.5
|
|
Post-CMR coronary bypass grafting
|
0.62 (0.41-0.93)
|
0.02
|
|
Post-CMR mitral valve repair/replacement
|
1.10 (0.68-1.79)
|
0.7
|
|
Post-CMR defibrillator/resynchronization therapy
|
0.73 (0.45-1.20)
|
0.2
|
|
Echocardiographic variables
| | |
|
Vena contracta
|
5.70 (2.94-11.04)
|
< 0.001
|
|
CMR variables
| | |
|
LV ejection fraction
|
0.98 (0.96-1.003)
|
0.1
|
|
LV end-diastolic volume index
|
1.004 (0.99-1.008)
|
0.1
|
|
Indexed left atrial volume
|
1.006 (0.99-1.02)
|
0.3
|
|
Indexed (D1+D2+D3)/3L (cm/m2)
|
1.23 (1.06-1.44)
|
0.007
|
|
Semiquantitative total scar score
|
1.21 (1.00-1.46)
|
0.04
|
|
Semiquantitative regional scar score
| | |
|
Anterior
|
1.06 (0.90-1.23)
|
0.5a
|
|
Lateral
|
1.13 (0.97-1.31)
|
0.1
|
|
Inferior
|
1.24 (1.06-1.44)
|
0.008
|
